These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21873107)

  • 1. The antibiotic R&D pipeline: an update.
    Jabes D
    Curr Opin Microbiol; 2011 Oct; 14(5):564-9. PubMed ID: 21873107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic discovery in the twenty-first century: current trends and future perspectives.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    J Antibiot (Tokyo); 2010 Aug; 63(8):423-30. PubMed ID: 20551985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding and enhancing our antibacterial arsenal.
    Collins JJ; Donadio S
    Curr Opin Microbiol; 2011 Oct; 14(5):511-2. PubMed ID: 21945218
    [No Abstract]   [Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global need for effective antibiotics: challenges and recent advances.
    Högberg LD; Heddini A; Cars O
    Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sources of novel antibiotics--aside the common roads.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    Appl Microbiol Biotechnol; 2010 Dec; 88(6):1261-7. PubMed ID: 20865256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future antibiotics scenarios: is the tide starting to turn?
    Theuretzbacher U
    Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
    Freire-Moran L; Aronsson B; Manz C; Gyssens IC; So AD; Monnet DL; Cars O;
    Drug Resist Updat; 2011 Apr; 14(2):118-24. PubMed ID: 21435939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
    Fernandes P; Pizza M
    Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of SBDD to the discovery of new antibacterial drugs.
    Finn J
    Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G
    Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategies for combating multidrug-resistant bacteria.
    Wright GD; Sutherland AD
    Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2012 and beyond: potential for the start of a second pre-antibiotic era?
    Appelbaum PC
    J Antimicrob Chemother; 2012 Sep; 67(9):2062-8. PubMed ID: 22687888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
    Infectious Diseases Society of America
    Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting current understanding of antibiotic action for discovery of new drugs.
    Chopra I; Hesse L; O'Neill AJ
    Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of broad-spectrum antibiofilm drugs: strategies and challenges.
    Dharmaprakash A; Thandavarayan R; Joseph I; Thomas S
    Future Microbiol; 2015; 10(6):1035-48. PubMed ID: 26059624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance is ancient: implications for drug discovery.
    Wright GD; Poinar H
    Trends Microbiol; 2012 Apr; 20(4):157-9. PubMed ID: 22284896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.